Establishment Labs (ESTA)
(Real Time Quote from BATS)
$50.23 USD
+0.54 (1.09%)
Updated Apr 24, 2024 10:28 AM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Income Statements
Fiscal Year end for Establishment Labs Holdings Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 165 | 162 | 127 | 85 | 90 |
Cost Of Goods | 58 | 55 | 41 | 32 | 35 |
Gross Profit | 107 | 107 | 85 | 53 | 55 |
Selling & Adminstrative & Depr. & Amort Expenses | 172 | 146 | 111 | 80 | 86 |
Income After Depreciation & Amortization | -65 | -40 | -25 | -28 | -31 |
Non-Operating Income | 2 | -21 | -6 | -1 | 2 |
Interest Expense | 15 | 12 | 9 | 9 | 9 |
Pretax Income | -79 | -73 | -40 | -38 | -38 |
Income Taxes | 0 | 2 | 1 | 0 | 1 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -79 | -75 | -41 | -38 | -38 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -79 | -75 | -41 | -38 | -38 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -60 | -27 | -19 | -24 | -28 |
Depreciation & Amortization (Cash Flow) | 5 | 12 | 6 | 4 | 3 |
Income After Depreciation & Amortization | -65 | -40 | -25 | -28 | -31 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 25.60 | 24.46 | 23.97 | 23.32 | 20.54 |
Diluted EPS Before Non-Recurring Items | -3.07 | -2.46 | -1.72 | -1.55 | -1.86 |
Diluted Net EPS (GAAP) | -3.07 | -3.08 | -1.72 | -1.63 | -1.86 |
Fiscal Year end for Establishment Labs Holdings Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 31.56 | 38.51 | 48.56 | 46.52 |
Cost Of Goods | NA | 10.98 | 12.45 | 18.30 | 16.45 |
Gross Profit | NA | 20.59 | 26.05 | 30.26 | 30.08 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 42.70 | 47.09 | 43.98 | 38.24 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -22.11 | -21.04 | -13.72 | -8.16 |
Non-Operating Income | NA | 3.41 | -3.89 | 1.51 | 0.80 |
Interest Expense | NA | 4.34 | 3.68 | 3.62 | 3.76 |
Pretax Income | NA | -23.05 | -28.60 | -15.82 | -11.11 |
Income Taxes | NA | -2.51 | 0.67 | 0.93 | 0.83 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -20.54 | -29.27 | -16.75 | -11.94 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -20.54 | -29.27 | -16.75 | -11.94 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 26.06 | 26.03 | 25.62 | 24.68 |
Diluted EPS Before Non-Recurring Items | NA | -0.79 | -1.12 | -0.65 | -0.48 |
Diluted Net EPS (GAAP) | NA | -0.82 | -1.12 | -0.65 | -0.48 |